Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
Neil J. Shimwell, Richard T. Bryan, Wenbin Wei, et al.
British Journal of Cancer (2013) Vol. 108, Iss. 9, pp. 1854-1861
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target
Panagiota S. Filippou, George S. Karagiannis, Anastasia Constantinidou
Oncogene (2019) Vol. 39, Iss. 10, pp. 2040-2054
Open Access | Times Cited: 239
Integrating transcriptome and proteome profiling: Strategies and applications
Dhirendra Kumar, Gourja Bansal, Ankita Narang, et al.
PROTEOMICS (2016) Vol. 16, Iss. 19, pp. 2533-2544
Closed Access | Times Cited: 157
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development
Maria Frantzi, Akshay Bhat, Agnieszka Latosińska
Clinical and Translational Medicine (2014) Vol. 3, Iss. 1
Open Access | Times Cited: 117
Urine Sample Preparation in 96-Well Filter Plates for Quantitative Clinical Proteomics
Yanbao Yu, Moo‐Jin Suh, Patricia Sikorski, et al.
Analytical Chemistry (2014) Vol. 86, Iss. 11, pp. 5470-5477
Open Access | Times Cited: 91
Developing proteomic biomarkers for bladder cancer: towards clinical application
Maria Frantzi, Agnieszka Latosińska, Leif Flühe, et al.
Nature Reviews Urology (2015) Vol. 12, Iss. 6, pp. 317-330
Closed Access | Times Cited: 77
Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma
Shih-Yi Lin, Chao-Hsiang Chang, His-Chin Wu, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 73
Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena
Richard T. Bryan
Philosophical Transactions of the Royal Society B Biological Sciences (2014) Vol. 370, Iss. 1661, pp. 20140042-20140042
Open Access | Times Cited: 56
Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer
Chien‐Lun Chen, Ting Chung, Chih‐Ching Wu, et al.
Molecular & Cellular Proteomics (2015) Vol. 14, Iss. 9, pp. 2466-2478
Open Access | Times Cited: 55
Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma
Viktor Soukup, Marta Kalousová, Otakar Čapoun, et al.
Urologia Internationalis (2015) Vol. 95, Iss. 1, pp. 56-64
Closed Access | Times Cited: 41
Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer
Marine Charpentier, Charly Gutierrez, Thierry Guillaudeux, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1650-1650
Open Access | Times Cited: 29
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
Richard T. Bryan, Neil J. Shimwell, Wenbin Wei, et al.
British Journal of Cancer (2013) Vol. 110, Iss. 3, pp. 679-685
Open Access | Times Cited: 42
Optimization for peptide sample preparation for urine peptidomics
Tara K. Sigdel, Carrie Nicora, Szu‐Chuan Hsieh, et al.
Clinical Proteomics (2014) Vol. 11, Iss. 1
Open Access | Times Cited: 36
Targeted Proteomics Pipeline Reveals Potential Biomarkers for the Diagnosis of Metastatic Lung Cancer in Pleural Effusion
Chi-De Chen, Chih‐Liang Wang, Chia‐Jung Yu, et al.
Journal of Proteome Research (2014) Vol. 13, Iss. 6, pp. 2818-2829
Closed Access | Times Cited: 35
Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation
Takayuki Ishige, Motoi Nishimura, Mamoru Satoh, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 29
Discovery of Novel Protein Biomarkers in Urine for Diagnosis of Urothelial Cancer Using iTRAQ Proteomics
Chao‐Jung Chen, Che‐Yi Chou, Kuo-Hsiung Shu, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 5, pp. 2953-2963
Closed Access | Times Cited: 23
Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
Yichi Zhang, Yifeng Lin, Daojun Lv, et al.
PeerJ (2022) Vol. 10, pp. e12843-e12843
Open Access | Times Cited: 16
Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions
Maria Frantzi, Antonia Vlahou
Bladder Cancer (2017) Vol. 3, Iss. 1, pp. 1-18
Open Access | Times Cited: 24
Integrative analysis to select cancer candidate biomarkers to targeted validation
Rebeca Kawahara, Gabriela Vaz Meirelles, Henry Heberle, et al.
Oncotarget (2015) Vol. 6, Iss. 41, pp. 43635-43652
Open Access | Times Cited: 21
Identification and validation of a poor clinical outcome subtype of primary prostate cancer with Midkine abundance
Quan Zhou, Chen Yang, Zezhong Mou, et al.
Cancer Science (2022) Vol. 113, Iss. 11, pp. 3698-3709
Open Access | Times Cited: 12
Proteomics strategies for urothelial bladder cancer diagnosis, prognosis and treatment: Trends for tumor biomarker sources
Samira Tabaei, Mohammad Reza Haghshenas, Thomas J. Webster, et al.
Analytical Biochemistry (2023) Vol. 666, pp. 115074-115074
Closed Access | Times Cited: 7
YAP1 induces bladder cancer progression and promotes immune evasion through IL-6/ STAT3 pathway and CXCL deregulation
Pritam Sadhukhan, Mingxiao Feng, Emily Illingworth, et al.
Journal of Clinical Investigation (2024) Vol. 135, Iss. 2
Open Access | Times Cited: 2
Recent developments in proteomic methods and disease biomarkers
Nina Bergman, Jonas Bergquist
The Analyst (2014) Vol. 139, Iss. 16, pp. 3836-3851
Closed Access | Times Cited: 19
Site-specific characterization of N-linked glycosylation in human urinary glycoproteins and endogenous glycopeptides
Rebeca Kawahara, Joyce Silva Saad, Cláudia B. Angeli, et al.
Glycoconjugate Journal (2016) Vol. 33, Iss. 6, pp. 937-951
Closed Access | Times Cited: 17
Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?
Nada Humayun-Zakaria, Douglas G. Ward, Roland Arnold, et al.
Translational Andrology and Urology (2021) Vol. 10, Iss. 6, pp. 2787-2808
Open Access | Times Cited: 14
Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics
Yi‐Ting Chen, Cheng-Han Tsai, Chien‐Lun Chen, et al.
Journal of Food and Drug Analysis (2018) Vol. 27, Iss. 2, pp. 387-403
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top